# N-Acetylcysteine for Youth Cannabis Use Disorder

> **NCT03055377** · PHASE2,PHASE3 · COMPLETED · sponsor: **Medical University of South Carolina** · enrollment: 192 (actual)

## Conditions studied

- Cannabis Use Disorder

## Interventions

- **DRUG:** N-acetyl cysteine
- **DRUG:** Placebo oral capsule

## Key facts

- **NCT ID:** NCT03055377
- **Lead sponsor:** Medical University of South Carolina
- **Sponsor class:** OTHER
- **Phase:** PHASE2,PHASE3
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2017-08-03
- **Primary completion:** 2024-01-31
- **Final completion:** 2024-02-26
- **Target enrollment:** 192 (ACTUAL)
- **Last updated:** 2024-12-17


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT03055377

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT03055377, "N-Acetylcysteine for Youth Cannabis Use Disorder". Retrieved via AI Analytics 2026-06-02 from https://api.ai-analytics.org/clinical/NCT03055377. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*